Larvol Delta - Alentis-Therapeutics-Receives-FDA-Fast-Track-Designation-for-ALEC04-for-the-Treatment-of-Claudin1-Positive-HNSCC

ALE.C04 - Alentis Therap

https://www.businesswire.com/news/home/20230824203671/en/Alentis-Therapeutics-Receives-FDA-Fast-Track-Designation-for-ALE.C04-for-the-Treatment-of-Claudin-1-Positive-HNSCC

Aug 24, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next